CoChat
Sign Up
Cited by 484Influenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Nichol, Kristin L., Wuorenma, J., von Sternberg, T.·1998·Archives of Internal Medicine
DOI 10.1001/archinte.158.16.1769
Open this paper in CoChat — free account

Abstract

BACKGROUND: Vaccination rates for healthy senior citizens are lower than those for senior citizens with underlying medical conditions such as chronic heart or lung disease. Uncertainty about the benefits of influenza vaccination for healthy senior citizens may contribute to lower rates of utilization in this group. OBJECTIVE: To clarify the benefits of influenza vaccination among low-risk senior citizens while concurrently assessing the benefits for intermediate- and high-risk senior citizens. METHODS: All elderly members of a large health maintenance organization were included in each of 6 consecutive study cohorts. Subjects were grouped according to risk status: high risk (having heart or lung disease), intermediate risk (having diabetes, renal disease, stroke and/or dementia, or rheumatologic disease), and low risk. Outcomes were compared between vaccinated and unvaccinated subjects after controlling for baseline demographic and health characteristics. RESULTS: There were more than 20000 subjects in each of the 6 cohorts who provided 147551 person-periods of observation. The pooled vaccination rate was 60%. There were 101 619 person-periods of observation for low-risk subjects, 15 482 for intermediate-risk, and 30 450 for high-risk subjects. Vaccination over the 6 seasons was associated with an overall reduction of 39% for pneumonia hospitalizations (P<.001), a 32% decrease in hospitalizations for all respiratory conditions (P<.001), and a 27% decrease in hospitalizations for congestive heart failure (P<.001). Immunization was also associated with a 50% reduction in all-cause mortality (P<.001). Within the risk subgroups, vaccine effectiveness was 29%, 32%, and 49% for high-, intermediate-, and low-risk senior citizens for reducing hospitalizations for pneumonia and influenza (for high and low risk, P< or =.002; for intermediate risk, P = .11). Effectiveness was 19%, 39%, and 33% (for each, P< or =.008), respectively, for reducing hospitalizations for all respiratory conditions and 49%, 64%, and 55% for reducing deaths from all causes (for each, P<.001). Vaccination was also associated with direct medical care cost savings of $73 per individual vaccinated for all subjects combined (P = .002). Estimates of cost savings within each risk group suggest that vaccination would be cost saving for each subgroup (range of cost savings of $171 per individual vaccinated for high risk to $7 for low risk), although within the subgroups these findings did not reach statistical significance (for each, P> or =.05). CONCLUSIONS: This study confirms that healthy senior citizens as well as senior citizens with underlying medical conditions are at risk for the serious complications of influenza and benefit from vaccination. All individuals 65 years or older should be immunized with this vaccine.

Overview

Integrity signals

Registry

Crossref · 10.1001/archinte.158.16.1769

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 41 references

Cited by

Sorted by citations

Items 401–480 of 480

Related

See all

Metadata

Authors
Nichol, K. L., Wuorenma, J., & von Sternberg, T.
Affiliations
  • University of Minnesota (US)
  • Regions Hospital (US)
Venue
Archives of Internal Medicine
Publisher
American Medical Association (AMA)
Published
1998-09-14
Volume
158
Issue
16
Pages
1769
ISSN
0003-9926 (ISSN-L)
DOI
10.1001/archinte.158.16.1769
OpenAlex
W2056095352
Cited by
484
References
41
Citations by year
2025: 3 · 2024: 1 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 9 · 2012: 16
FWCI
15.05
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
influenza vaccination, older adults, vaccine effectiveness, pneumonia hospitalization, respiratory hospitalization, congestive heart failure, all-cause mortality, risk stratification, cost reduction, vaccination coverage, health maintenance organizations, diabetes mellitus, kidney disease, dementia, rheumatic diseases
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Influenza, Human, Influenza Vaccines, Male, Risk, Risk Factors, Seasons, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review